Xencor (XNCR) Assets (2013 - 2026)
Xencor's (XNCR) quarterly Assets came in at $736.8 million in Q1 2026, down 18.55% year-on-year from $904.7 million in Q1 2025, and down 15.84% on a QoQ basis from $875.5 million in Q4 2025.
Xencor (XNCR) Assets (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Assets data on file, last reported at $736.8 million in Q1 2026.
- On a quarterly basis, Assets fell 18.55% year-over-year to $736.8 million in Q1 2026; TTM through Mar 2026 was $736.8 million, a 18.55% decrease from a year earlier, with the FY2025 full-year figure at $875.5 million, down 8.03% from the prior year.
- Assets for Q1 2026 stood at $736.8 million, down from $875.5 million in the prior quarter.
- Over the last five years, Assets for XNCR reached as high as $999.9 million in Q3 2024 and fell as low as $736.8 million in Q1 2026.
- Historically, Assets has averaged $863.0 million across 5 years, with a median of $857.9 million in 2022.
- Across the five-year window, Assets increased 28.45% in 2024 and retreated 18.55% in 2026, its largest moves.
- Year by year, Assets stood at $846.3 million in 2022, then rose by 14.05% to $965.1 million in 2023, then decreased by 1.37% to $951.9 million in 2024, then declined by 8.03% to $875.5 million in 2025, then fell by 15.84% to $736.8 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $736.8 million in Q1 2026, $875.5 million in Q4 2025, and $868.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 311.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 78.88 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.55 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 39.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.48 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.87 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 811.27 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 10.03 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.25 Bn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 736.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 736.85 Mn |
| Dec 31, 2025 | 875.50 Mn |
| Sep 30, 2025 | 868.81 Mn |
| Jun 30, 2025 | 879.42 Mn |
| Mar 31, 2025 | 904.69 Mn |
| Dec 31, 2024 | 951.95 Mn |
| Sep 30, 2024 | 999.90 Mn |
| Jun 30, 2024 | 840.62 Mn |
| Mar 31, 2024 | 896.85 Mn |
| Dec 31, 2023 | 965.14 Mn |
| Sep 30, 2023 | 778.43 Mn |
| Jun 30, 2023 | 778.12 Mn |
| Mar 31, 2023 | 803.41 Mn |
| Dec 31, 2022 | 846.27 Mn |
| Sep 30, 2022 | 835.27 Mn |
| Jun 30, 2022 | 851.33 Mn |
| Mar 31, 2022 | 857.92 Mn |
| Dec 31, 2021 | 838.21 Mn |
| Sep 30, 2021 | 697.26 Mn |
| Jun 30, 2021 | 695.60 Mn |